Free Trial
→ The End of Elon Musk…? (From Brownstone Research) (Ad) Free LLY Stock Alerts

Eli Lilly and Company (LLY) Short Interest Ratio & Short Volume

Eli Lilly and Company logo
$791.78 +20.03 (+2.60%)
As of 10:54 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
Compare

Eli Lilly and Company Short Interest Data

Eli Lilly and Company (LLY) has a short interest of 7.71 million shares, representing 0.91% of the float (the number of shares available for trading by the public). This marks a -3.87% decrease in short interest from the previous month. The short interest ratio (days to cover) is 1.9, indicating that it would take 1.9 days of the average trading volume of 3.67 million shares to cover all short positions.

Current Short Interest
7,710,000 shares
Previous Short Interest
8,020,000 shares
Change Vs. Previous Month
-3.87%
Dollar Volume Sold Short
$6.01 billion
Short Interest Ratio
1.9 Days to Cover
Last Record Date
June 30, 2025
Outstanding Shares
947,740,000 shares
Float Size
849,660,000 shares
Short Percent of Float
0.91%
Today's Trading Volume
763,033 shares
Average Trading Volume
3,667,450 shares
Today's Volume Vs. Average
21%
Short Selling Eli Lilly and Company?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Eli Lilly and Company and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

LLY Short Interest Over Time

LLY Days to Cover Over Time

LLY Percentage of Float Shorted Over Time

Eli Lilly and Company Short Interest History

Export to Excel
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
6/30/20257,710,000 shares $6.01 billion -3.9%0.9%1.9 $779.35
6/15/20258,020,000 shares $6.56 billion -0.1%0.9%2 $818.56
5/31/20258,030,000 shares $5.93 billion +9.3%1.0%1.9 $738.33
5/15/20257,350,000 shares $5.38 billion No Change0.9%1.8 $732.40
4/30/20257,350,000 shares $6.61 billion +14.3%0.9%1.9 $899.78
4/15/20256,430,000 shares $4.86 billion -8.4%0.8%1.8 $756.55
3/31/20257,020,000 shares $5.79 billion +10.4%0.8%1.9 $825.42
3/15/20256,360,000 shares $5.17 billion -12.2%0.8%1.7 $813.55
2/28/20257,240,000 shares $6.66 billion +2.3%0.9%2 $920.44
2/15/20257,080,000 shares $5.98 billion +4.6%0.8%1.9 $844.82
1/31/20256,770,000 shares $5.49 billion -6.2%0.8%1.7 $811.61
1/15/20257,220,000 shares $5.39 billion +18.4%0.9%1.7 $746.42
12/31/20246,100,000 shares $4.71 billion +5.4%0.7%1.6 $772.00
12/15/20245,790,000 shares $4.57 billion -0.9%0.7%1.5 $789.12
11/30/20245,840,000 shares $4.64 billion -10.7%0.7%1.6 $795.35
11/15/20246,540,000 shares $4.88 billion -1.2%0.8%1.8 $745.89
10/31/20246,620,000 shares $5.49 billion +14.3%0.8%2.1 $829.84
10/15/20245,790,000 shares $5.29 billion No Change0.7%2 $913.85
9/30/20245,790,000 shares $5.13 billion -12.0%0.7%1.8 $885.56
9/15/20246,580,000 shares $6.08 billion +4.9%0.8%2 $923.71
8/31/20246,270,000 shares $6.02 billion -0.5%0.7%1.9 $960.02
8/15/20246,300,000 shares $5.87 billion +16.5%0.7%2 $931.58
7/31/20245,410,000 shares $4.35 billion -14.3%0.6%1.8 $804.27
7/15/20246,310,000 shares $6.00 billion +5.3%0.7%2.2 $950.46
6/30/20245,990,000 shares $5.42 billion -7.6%0.7%2.2 $905.38
6/15/20246,480,000 shares $5.69 billion +5.2%0.8%2.5 $878.45
5/31/20246,160,000 shares $5.06 billion +14.1%0.7%2.3 $821.11
5/15/20245,400,000 shares $4.25 billion +5.7%0.6%2 $787.24
4/30/20245,110,000 shares $3.99 billion -7.8%0.6%1.7 $781.56
4/15/20245,540,000 shares $4.16 billion +2.2%0.7%1.8 $751.20
3/31/20245,420,000 shares $4.22 billion -2.2%0.6%1.8 $777.96
3/15/20245,540,000 shares $4.18 billion +2.2%0.7%1.8 $755.36
2/29/20245,420,000 shares $4.08 billion +5.2%0.6%1.7 $753.61
2/15/20245,150,000 shares $3.90 billion +16.8%0.6%1.6 $757.09
1/31/20244,410,000 shares $2.84 billion -9.8%0.5%1.3 $645.10
1/15/20244,890,000 shares $3.14 billion -3.9%0.6%1.6 $642.92
12/31/20235,090,000 shares $2.97 billion -4.7%0.6%1.6 $582.92
12/15/20235,340,000 shares $3.05 billion -3.3%0.6%1.7 $571.46
11/30/20235,520,000 shares $3.26 billion -5.5%0.7%1.7 $591.04
11/15/20235,840,000 shares $3.44 billion +6.8%0.7%1.8 $588.41
3..2..1.. AI 2.0 ignition (don’t sleep on this) (Ad)

I just put together an urgent new presentation that you need to see right away. In short: I believe we are mere days away from a critical announcement from a key tech leader… One that will officially ignite “AI 2.0” – and potentially send a whole new class of stocks soaring.

Click to find out what Nvidia’s CEO might reveal… and how Sykes is preparing to ride the wave.
10/31/20235,470,000 shares $3.03 billion -14.4%0.7%1.8 $553.93
10/15/20236,390,000 shares $3.89 billion +13.1%0.8%2.1 $609.20
9/30/20235,650,000 shares $3.03 billion -9.9%0.7%1.9 $537.13
9/15/20236,270,000 shares $3.61 billion +11.6%0.7%2.2 $575.66
8/31/20235,620,000 shares $3.11 billion +8.3%0.7%2 $554.20
8/15/20235,190,000 shares $2.84 billion +8.6%0.6%1.8 $546.64
7/31/20234,780,000 shares $2.17 billion -7.0%0.6%1.7 $454.55
7/15/20235,140,000 shares $2.31 billion -1.9%0.6%1.7 $449.46
6/30/20235,240,000 shares $2.46 billion -7.8%0.6%1.8 $468.98
6/15/20235,680,000 shares $2.58 billion -5.3%0.7%1.9 $454.00
5/31/20236,000,000 shares $2.58 billion -1.6%0.7%1.9 $429.46
5/15/20236,100,000 shares $2.65 billion -1.6%0.7%1.9 $434.51
4/30/20236,200,000 shares $2.45 billion -18.1%0.7%1.9 $395.86
4/15/20237,570,000 shares $2.84 billion +4.7%0.9%2.4 $374.73
3/31/20237,230,000 shares $2.48 billion -11.0%0.9%2.2 $343.42
3/15/20238,120,000 shares $2.68 billion +19.2%1.0%2.7 $329.47
2/28/20236,810,000 shares $2.12 billion +30.5%0.8%2.4 $311.22
2/15/20235,220,000 shares $1.75 billion +5.9%0.6%1.9 $335.01
1/31/20234,930,000 shares $1.70 billion No Change0.6%1.7 $344.15
1/15/20234,930,000 shares $1.78 billion -12.3%0.6%1.7 $361.62
12/30/20225,620,000 shares $2.06 billion No Change0.6%2 $365.84
12/15/20225,620,000 shares $2.02 billion -15.0%0.6%1.8 $360.01
11/30/20226,610,000 shares $2.45 billion +17.8%0.8%2.2 $371.08
11/15/20225,610,000 shares $1.96 billion -8.0%0.7%1.9 $349.95
10/31/20226,100,000 shares $2.21 billion +12.6%0.7%2.1 $362.09
10/15/20225,420,000 shares $1.80 billion -5.7%0.6%1.9 $331.39
9/30/20225,750,000 shares $1.86 billion +7.9%0.7%2.1 $323.35
9/15/20225,330,000 shares $1.65 billion +2.9%0.6%2 $309.47
8/31/20225,180,000 shares $1.56 billion +7.5%0.7%2 $301.23
8/15/20224,820,000 shares $1.51 billion -2.8%0.6%1.7 $313.94
7/31/20224,960,000 shares $1.64 billion -9.2%0.6%1.7 $329.69
7/15/20225,460,000 shares $1.81 billion +10.8%0.7%1.9 $331.60
6/30/20224,930,000 shares $1.60 billion +14.9%0.6%1.7 $324.23
6/15/20224,290,000 shares $1.26 billion -16.2%0.5%1.4 $292.99
5/31/20225,120,000 shares $1.60 billion -2.1%0.7%1.7 $313.44
5/15/20225,230,000 shares $1.53 billion +4.0%0.7%1.8 $291.63
4/30/20225,030,000 shares $1.47 billion -19.1%0.6%1.7 $292.13
4/15/20226,220,000 shares $1.88 billion +7.4%0.8%2.2 $301.86
3/31/20225,790,000 shares $1.66 billion -12.1%0.7%1.9 $286.37
3/15/20226,590,000 shares $1.82 billion +1.4%0.8%2.3 $275.46
2/28/20226,500,000 shares $1.62 billion +21.3%0.8%2.2 $249.95
2/15/20225,360,000 shares $1.31 billion +13.3%0.7%1.7 $243.84
1/31/20224,730,000 shares $1.16 billion +8.0%0.6%1.6 $245.39
1/15/20224,380,000 shares $1.07 billion -8.6%0.6%1.4 $244.12
12/31/20214,790,000 shares $1.32 billion -22.6%0.6%1.6 $276.22
12/15/20216,190,000 shares $1.70 billion +4.0%0.8%2 $275.28
11/30/20215,950,000 shares $1.48 billion -16.7%0.8%2 $248.04
11/15/20217,140,000 shares $1.85 billion -19.2%0.9%2.7 $258.43
10/29/20218,840,000 shares $2.25 billion +34.6%1.1%3.3 $254.76
10/15/20216,570,000 shares $1.56 billion +2.5%0.8%2.6 $237.88
3..2..1.. AI 2.0 ignition (don’t sleep on this) (Ad)

I just put together an urgent new presentation that you need to see right away. In short: I believe we are mere days away from a critical announcement from a key tech leader… One that will officially ignite “AI 2.0” – and potentially send a whole new class of stocks soaring.

Click to find out what Nvidia’s CEO might reveal… and how Sykes is preparing to ride the wave.
9/30/20216,410,000 shares $1.48 billion +11.5%0.8%2.5 $231.05
9/15/20215,750,000 shares $1.34 billion -6.5%0.7%2.1 $233.73
8/31/20216,150,000 shares $1.59 billion No Change0.8%2.2 $258.29
8/13/20216,150,000 shares $1.62 billion -9.2%0.8%1.9 $264.21
7/30/20216,770,000 shares $1.65 billion -3.4%0.9%2.1 $243.50
7/15/20217,010,000 shares $1.62 billion +12.0%0.9%2.1 $231.47
6/30/20216,260,000 shares $1.44 billion -17.6%0.8%1.8 $229.52
6/15/20217,600,000 shares $1.70 billion +0.1%1.0%2.2 $223.52
5/28/20217,590,000 shares $1.52 billion -8.4%1.0%2.1 $199.74
5/14/20218,290,000 shares $1.62 billion -7.0%1.0%2.5 $194.94
4/30/20218,910,000 shares $1.62 billion +39.7%1.1%2.6 $182.20
4/15/20216,380,000 shares $1.17 billion -17.4%0.8%1.7 $183.00
3/31/20217,720,000 shares $1.43 billion +10.6%1.0%1.8 $185.50
3/15/20216,980,000 shares $1.45 billion +23.8%0.9%1.6 $208.08
2/26/20215,640,000 shares $1.15 billion -14.0%0.7%1.3 $203.82
2/12/20216,560,000 shares $1.33 billion -1.7%0.8%1.5 $202.58
1/29/20216,670,000 shares $1.40 billion +15.8%0.8%1.5 $210.12
1/15/20215,760,000 shares $1.08 billion +10.8%0.7%1.2 $186.69
12/31/20205,200,000 shares $868.45 million -24.5%0.7%1.2 $167.01
12/15/20206,890,000 shares $1.09 billion +24.1%0.9%1.7 $157.91
11/30/20205,550,000 shares $818.29 million +4.1%0.7%1.3 $147.44
11/15/20205,330,000 shares $758.89 million +9.0%0.7%1.3 $142.38
10/30/20204,890,000 shares $648.17 million -7.4%0.6%1.3 $132.55
10/15/20205,280,000 shares $783.87 million +40.1%0.7%1.6 $148.46
9/30/20203,770,000 shares $558.04 million -39.9%0.5%1.2 $148.02
9/15/20206,270,000 shares $941.00 million +34.6%0.8%2 $150.08
8/31/20204,660,000 shares $691.50 million +9.7%0.6%1.5 $148.39
8/14/20204,250,000 shares $637.88 million -5.8%0.5%1.2 $150.09
7/31/20204,510,000 shares $677.81 million -13.8%0.5%1.3 $150.29

LLY Short Interest - Frequently Asked Questions

What is Eli Lilly and Company's current short interest?

Short interest is the volume of Eli Lilly and Company shares that have been sold short but have not yet been covered or closed out. As of June 30th, traders have sold 7,710,000 shares of LLY short. 0.91% of Eli Lilly and Company's shares are currently sold short. Learn More on Eli Lilly and Company's current short interest.

What is a good short interest ratio for Eli Lilly and Company?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. LLY shares currently have a short interest ratio of 2.0. Learn More on Eli Lilly and Company's short interest ratio.

Which institutional investors are shorting Eli Lilly and Company?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Eli Lilly and Company: Fortitude Family Office LLC, Dynamic Advisor Solutions LLC, Modern Wealth Management LLC, Quaker Wealth Management LLC, CTC LLC, Goldman Sachs Group Inc., Select Equity Group L.P., Parallax Volatility Advisers L.P., Millennium Management LLC, 683 Capital Management LLC, Nantahala Capital Management LLC, Cubist Systematic Strategies LLC, MAI Capital Management, Nomura Holdings Inc., DRW Securities LLC, Twin Tree Management LP, Susquehanna International Group LLP, Tortoise Investment Management LLC, BNP Paribas Financial Markets, Eisler Capital Management Ltd., PEAK6 LLC, Jane Street Group LLC, Walleye Trading LLC, Walleye Capital LLC, New Harbor Financial Group LLC, Capital Fund Management S.A., Credit Agricole S A, Hsbc Holdings PLC, Maven Securities LTD, Cresset Asset Management LLC, Persistent Asset Partners Ltd, HighTower Advisors LLC, Simplex Trading LLC, JPMorgan Chase & Co., Wolverine Asset Management LLC, National Bank of Canada FI, Citigroup Inc., XY Capital Ltd, Gladius Capital Management LP, US Bancorp DE, Bedel Financial Consulting Inc., Brandywine Oak Private Wealth LLC, Readystate Asset Management LP, Allianz Asset Management GmbH, Caas Capital Management LP, Valeo Financial Advisors LLC, Bank of New York Mellon Corp, Novem Group, Fulcrum Asset Management LLP, Johnson Investment Counsel Inc., Halbert Hargrove Global Advisors LLC, Mission Wealth Management LP, and Dynamic Advisor Solutions LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Eli Lilly and Company?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.91% of Eli Lilly and Company's floating shares are currently sold short.

Is Eli Lilly and Company's short interest increasing or decreasing?

Eli Lilly and Company saw a drop in short interest in June. As of June 30th, there was short interest totaling 7,710,000 shares, a drop of 3.9% from the previous total of 8,020,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Eli Lilly and Company's float size?

Eli Lilly and Company currently has issued a total of 947,740,000 shares. Some of Eli Lilly and Company's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Eli Lilly and Company currently has a public float of 849,660,000 shares.

How does Eli Lilly and Company's short interest compare to its competitors?

0.91% of Eli Lilly and Company's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Eli Lilly and Company: Amgen Inc. (2.75%), Biogen Inc. (2.74%), Incyte Corporation (3.82%), Moderna, Inc. (19.15%), Viking Therapeutics, Inc. (0.03%), Vertex Pharmaceuticals Incorporated (1.50%), AbbVie Inc. (0.91%), Johnson & Johnson (0.66%), Merck & Co., Inc. (1.40%), Pfizer Inc. (1.97%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($72.10 billion), Invesco QQQ ($26.89 billion), iShares Russell 2000 ETF ($19.61 billion), MicroStrategy Incorporated ($9.52 billion), iShares 20+ Year Treasury Bond ETF ($8.70 billion), WD-40 Company ($7.66 billion), Technology Select Sector SPDR Fund ($6.10 billion), Invesco S&P 500 Equal Weight ETF ($5.80 billion), Invesco S&P 500 Top 50 ETF ($5.53 billion), and Vanguard Large-Cap ETF ($5.35 billion). View all of the most shorted stocks.

What does it mean to sell short Eli Lilly and Company stock?

Short selling LLY is an investing strategy that aims to generate trading profit from Eli Lilly and Company as its price is falling. LLY shares are trading down $26.60 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Eli Lilly and Company?

A short squeeze for Eli Lilly and Company occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of LLY, which in turn drives the price of the stock up even further.

How often is Eli Lilly and Company's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LLY, twice per month. The most recent reporting period available is June, 30 2025.



Related Companies
Short Interest Tools

This page (NYSE:LLY) was last updated on 7/16/2025 by MarketBeat.com Staff
From Our Partners
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsored
The Trump Dump is starting; Get out of stocks now?
The first 365 days of the Trump presidency… Will be the best time to get rich in American history.
Paradigm Press | Sponsored
The $7 company helping Nvidia build the world’s first trillion-dollar robot …
Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...
Weiss Ratings | Sponsored
Post-Halving = Profit Season (Here’s How to Win It)
It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...
Crypto Swap Profits | Sponsored
Trump’s treachery
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...
Porter & Company | Sponsored
Drilling With a $3.5B Discovery Partner in Its Corner
A small-cap explorer is about to drill for high-grade gold in a region known for multi-million-ounce discoveri...
The Tomorrow Investor | Sponsored
Is this secretive Asian company trying to take over Bitcoin?
A mysterious Asian conglomerate is buying billions in Bitcoin — but one legendary trader says that’s the wrong...
Brownstone Research | Sponsored
Bank of America Says Gold Could Hit $4,000. Here How to Get Paid
“I’ve always hated gold. It doesn’t pay dividends… it just sits there.” That’s what one income strategist b...
Investors Alley | Sponsored